Research is being reported on the in vitro activity of sulbactam in combination with other antimicrobial agents. The focus of this research is on its effectiveness against extensively drug-resistant Acinetobacter baumannii. The study examines the potential of sulbactam combinations as a treatment option for this type of bacterial infection.